NCT04860167

Brief Summary

This study was performed to evaluate the role of BIS monitored sedation in reducing the dose of propofol and to know the effectiveness of pre-procedure administration of intravenous diclofenac sodium along with topical pharyngeal anesthesia in reducing the dose of propofol in patients undergoing endoscopic retrograde cholangiopancreatography.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 10, 2018

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 26, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 14, 2019

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

April 19, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 26, 2021

Completed
Last Updated

April 26, 2021

Status Verified

April 1, 2021

Enrollment Period

1 year

First QC Date

April 19, 2021

Last Update Submit

April 22, 2021

Conditions

Keywords

DiclofenacPropofolTopical anaesthesia

Outcome Measures

Primary Outcomes (1)

  • Total dose of propofol required in mg/kg/hr during ERCP procedure among different groups.

    Total dose of propofol required to complete the ERCP procedure was noted

    2 hours

Secondary Outcomes (3)

  • Mean recovery time between different groups.

    24 hours

  • Time taken to achieve eye opening to verbal stimulus among different groups

    24 hours

  • Incidence of hypotension, bradycardia, limb movements and gag reflex during the ERCP procedure

    24 hours

Study Arms (3)

Group A

NO INTERVENTION

The intravenous infusion of propofol was administered for ERCP procedure based on clinical judgment and the patient's requirement.

Group B

ACTIVE COMPARATOR

The intravenous infusion of propofol was administered for ERCP procedure titrated to BIS value 60-80.

Drug: Propofol

Group C

ACTIVE COMPARATOR

Patients received 75 mg of inj. Diclofenac sodium (diluted in 100 ml of 0.9 % normal saline) intravenously 30 mins before the start of procedure \& topical pharyngeal anesthesia with 4 squirts of 10% lidocaine spray ( one squirt each to posterior pharyngeal wall, base of tongue, and bilateral palatoglossal and palatopharyngeal folds ) 5 mins before the start of ERCP procedure. Intravenous infusion of propofol was administered for ERCP procedure titrated to BIS value 60-80.

Drug: Diclofenac Sodium and Lignocaine 10 % spray

Interventions

Injection propofol was given to keep the BIS value 60-80 during the ERCP procedure

Also known as: Neorof
Group B

Injection Diclofenac sodium was given in the preoperative area 30 minutes before the procedure and four squirts of 10% lignocaine were given 5 minutes prior to the start of the procedure

Also known as: Dynapar
Group C

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 18-65 yrs
  • ASA I \& II

You may not qualify if:

  • Age \< 18 yrs \& \> 65 yrs
  • ASA III \& IV patients
  • Chronic Liver Disease
  • Pregnant patients
  • Patients with a history of (H/O) Drug abuse
  • Patients refusing consent
  • H/o Acute kidney injury
  • H/o allergy to propofol / lidocaine/ NSAIDS
  • Post liver transplant patients
  • Patients with h/o egg allergy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gaurav Sindwani

New Delhi, National Capital Territory of Delhi, 110060, India

Location

Related Publications (5)

  • Patai A, Solymosi N, Mohacsi L, Patai AV. Indomethacin and diclofenac in the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis of prospective controlled trials. Gastrointest Endosc. 2017 Jun;85(6):1144-1156.e1. doi: 10.1016/j.gie.2017.01.033. Epub 2017 Feb 4.

  • Quesada N, Judez D, Martinez Ubieto J, Pascual A, Chacon E, De Pablo F, Minchole E, Bello S. Bispectral Index Monitoring Reduces the Dosage of Propofol and Adverse Events in Sedation for Endobronchial Ultrasound. Respiration. 2016;92(3):166-75. doi: 10.1159/000448433. Epub 2016 Sep 7.

  • Wehrmann T, Grotkamp J, Stergiou N, Riphaus A, Kluge A, Lembcke B, Schultz A. Electroencephalogram monitoring facilitates sedation with propofol for routine ERCP: a randomized, controlled trial. Gastrointest Endosc. 2002 Dec;56(6):817-24. doi: 10.1067/mge.2002.129603.

  • White PF, Sacan O, Tufanogullari B, Eng M, Nuangchamnong N, Ogunnaike B. Effect of short-term postoperative celecoxib administration on patient outcome after outpatient laparoscopic surgery. Can J Anaesth. 2007 May;54(5):342-8. doi: 10.1007/BF03022655.

  • Paspatis GA, Chainaki I, Manolaraki MM, Vardas E, Theodoropoulou A, Tribonias G, Konstantinidis K, Karmiris K, Chlouverakis G. Efficacy of bispectral index monitoring as an adjunct to propofol deep sedation for ERCP: a randomized controlled trial. Endoscopy. 2009 Dec;41(12):1046-51. doi: 10.1055/s-0029-1215342. Epub 2009 Dec 4.

MeSH Terms

Interventions

PropofolDiclofenacLidocaine

Intervention Hierarchy (Ancestors)

PhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsPhenylacetatesAcids, CarbocyclicCarboxylic AcidsAcetanilidesAnilidesAmidesAniline CompoundsAmines

Study Officials

  • gaurav sindwani, md

    ilbs

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor, Department of Anaesthesiology, Principal Investigator

Study Record Dates

First Submitted

April 19, 2021

First Posted

April 26, 2021

Study Start

September 10, 2018

Primary Completion

September 26, 2019

Study Completion

November 14, 2019

Last Updated

April 26, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

Locations